NYPOZI txid
NDC 72374-101, filgrastim-txid, injection, from Tanvex BioPharma USA, Inc..
- Product NDC
- 72374-101
- Status
- Listed
- Labeler
- Tanvex BioPharma USA, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761126
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72374-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FILGRASTIM300 ug/300ug
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72374-101-01 | 72374010101 | 1 SYRINGE, GLASS in 1 CARTON (72374-101-01) / 300 ug in 1 SYRINGE, GLASS |
| 72374-101-10 | 72374010110 | 10 SYRINGE, GLASS in 1 CARTON (72374-101-10) / 300 ug in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/89092bb8-6a20-e23e-e053-2a95a90aa750Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72374-101
Use it
Look up 72374-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72374-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72374-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.